Advanced search
Publication Cover
Pragmatic and Observational Research Volume 14, 2023 - Issue
Submit an article Journal homepage
299
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Adult Severe Asthma Registries: A Global and Growing Inventory

Breda Cushen1 Department of Respiratory Medicine, Beaumont Hospital, Dublin, IrelandView further author information
,
Mariko Siyue Koh2 Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore, SingaporeView further author information
,
Trung N Tran3 AstraZeneca, Gaithersburg, MD, USAView further author information
,
Neil Martin3 AstraZeneca, Gaithersburg, MD, USA;4 Department of Respiratory Medicine, University of Leicester, Leicester, UKView further author information
,
Ruth Murray5 Optimum Patient Care Global, Cambridge, UKView further author information
,
Thendral Uthaman6 Observational Pragmatic Research Institute, Singapore, SingaporeView further author information
,
Celine Yun Yi Goh5 Optimum Patient Care Global, Cambridge, UK;6 Observational Pragmatic Research Institute, Singapore, SingaporeORCID Iconhttps://orcid.org/0000-0002-4571-8468View further author information
ORCID Icon,
Rebecca Vella7 Optimum Patient Care, Brisbane, Queensland, AustraliaORCID Iconhttps://orcid.org/0000-0001-5221-3524View further author information
ORCID Icon,
Neva Eleangovan5 Optimum Patient Care Global, Cambridge, UK;6 Observational Pragmatic Research Institute, Singapore, SingaporeView further author information
,
Lakmini Bulathsinhala5 Optimum Patient Care Global, Cambridge, UK;6 Observational Pragmatic Research Institute, Singapore, SingaporeView further author information
,
Jorge F Maspero8 Clinical Research for Allergy and Respiratory Medicine, CIDEA Foundation, Buenos Aires, Argentina;9 University Career of Specialists in Allergy and Clinical Immunology at the Buenos Aires University School of Medicine, Buenos Aires, ArgentinaView further author information
,
Matthew J Peters10 Department of Thoracic Medicine, Concord Hospital, Sydney, AustraliaView further author information
,
Florence Schleich11 CHU Sart-Tilman, GIGA I3, University of Liege, Liège, Wallonia, BelgiumView further author information
,
Paulo Pitrez12 Pulmonology Division, Hospital Santa Casa de Porto Alegre, Porto Alegre, BrazilView further author information
,
George Christoff13 Faculty of Public Health, Medical University, Sofia, BulgariaORCID Iconhttps://orcid.org/0000-0003-4549-7711View further author information
ORCID Icon,
Mohsen Sadatsafavi14 Respiratory Evaluation Sciences Program, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, CanadaORCID Iconhttps://orcid.org/0000-0002-0419-7862View further author information
ORCID Icon,
Carlos A Torres-Duque15 CINEUMO, Respiratory Research Center, Fundación Neumológica Colombiana, Bogotá, Colombia;16 Universidad de La Sabana, Chia, ColombiaORCID Iconhttps://orcid.org/0000-0003-0004-8955View further author information
ORCID Icon,
Celeste Porsbjerg17 Department of Respiratory Medicine and Infectious Diseases, Research Unit, Bispebjerg Hospital, Copenhagen, DenmarkView further author information
,
Alan Altraja18 Department of Pulmonology, University of Tartu and Lung Clinic, Tartu University Hospital, Tartu, EstoniaView further author information
,
Lauri Lehtimäki19 Allergy Centre, Tampere University Hospital, Faculty of Medicine and Health Technology, Tampere University, Tampere, FinlandORCID Iconhttps://orcid.org/0000-0003-1586-4998View further author information
ORCID Icon,
Arnaud Bourdin20 PhyMedExp, Univ Montpellier, CNRS, INSERM, CHU Montpellier, Montpellier, FranceORCID Iconhttps://orcid.org/0000-0002-4645-5209View further author information
ORCID Icon,
Christian Taube21 Department of Pulmonary Medicine, University Medical Center Essen-Ruhrlandklinik, Essen, GermanyView further author information
,
Nikolaos G Papadopoulos22 Division of Infection, Immunity & Respiratory Medicine, University of Manchester, Manchester, UK;23 Allergy Department, 2nd Pediatric Clinic, University of Athens, Athens, GreeceORCID Iconhttps://orcid.org/0000-0002-4448-3468View further author information
ORCID Icon,
Csoma Zsuzsanna24 Asthma Outpatient Clinic, National Koranyi Institute for Pulmonology, Budapest, HungaryView further author information
,
Unnur Björnsdóttir25 Department of Allergy and Respiratory Medicine, University Hospital, Reykjavik, IcelandView further author information
,
Sundeep Salvi26 Pulmocare Research and Education Foundation, Pune, IndiaView further author information
,
Enrico Heffler27 Personalized Medicine, Asthma and Allergy, IRCCS Humanitas Research Hospital, Rozzano, Milan, ItalyView further author information
,
Takashi Iwanaga28 Kindai University Hospital, Osakasayama, JapanORCID Iconhttps://orcid.org/0000-0001-9155-265XView further author information
ORCID Icon,
Mona al-Ahmad29 Microbiology Department, College of Medicine, Kuwait University, Kuwait, Al-Rashed Allergy Center, Ministry of Health, Kuwait City, KuwaitORCID Iconhttps://orcid.org/0000-0003-2950-5363View further author information
ORCID Icon,
Désirée Larenas-Linnemann30 Centro de Excelencia en Asma y Alergia, Hospital Médica Sur, Ciudad de México, MexicoORCID Iconhttps://orcid.org/0000-0002-5713-5331View further author information
ORCID Icon,
Job FM van Boven31 University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Department of Clinical Pharmacy & Pharmacology, Groningen, the NetherlandsORCID Iconhttps://orcid.org/0000-0003-2368-2262View further author information
ORCID Icon,
Bernt Bøgvald Aarli32 Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway;33 Department of Clinical Science, University of Bergen, Bergen, NorwayView further author information
,
Piotr Kuna34 Division of Internal Medicine Asthma and Allergy, Medical University of Lodz, Lodz, PolandView further author information
,
Cláudia Chaves Loureiro35 Pneumology Unit, Hospitais da Universidade de Coimbra, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal;36 Centre of Pneumology, Faculty of Medicine, University of Coimbra, Coimbra, PortugalView further author information
,
Riyad Al-lehebi37 Department of Pulmonology, King Fahad Medical City, Riyadh, Saudi Arabia, Alfaisal University, Riyadh, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0002-3232-6668View further author information
ORCID Icon,
Jae Ha Lee38 Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of KoreaORCID Iconhttps://orcid.org/0000-0003-0932-2826View further author information
ORCID Icon,
Nuria Marina39 Pneumology Service, Biocruces, Cruces University Hospital, Barakaldo, SpainView further author information
,
Leif Bjermer40 Respiratory Medicine and Allergology, Department of Clinical Sciences, Skåne University Hospital, Lund University, Lund, SwedenORCID Iconhttps://orcid.org/0000-0002-3441-8099View further author information
ORCID Icon,
Chau-Chyun Sheu41 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan;42 Department of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanORCID Iconhttps://orcid.org/0000-0002-7979-3749View further author information
ORCID Icon,
Bassam Mahboub43 Rashid Hospital, Dubai Health Authority (DHA), Dubai, United Arab EmiratesORCID Iconhttps://orcid.org/0000-0002-6089-438XView further author information
ORCID Icon,
John Busby44 Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast, Northern Ireland, UKView further author information
,
Andrew Menzies-Gow45 Lung Division, Royal Brompton & Harefield Hospital, London, UKView further author information
,
Eileen Wang46 Division of Allergy and Clinical Immunology, Department of Medicine, National Jewish Health and University of Colorado School of Medicine, Denver and Aurora, CO, USAView further author information
&
David B Price5 Optimum Patient Care Global, Cambridge, UK;6 Observational Pragmatic Research Institute, Singapore, Singapore;47 Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, Scotland, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9728-9992View further author information
ORCID Icon show all
Pages 127-147 | Received 06 Feb 2023, Accepted 11 Sep 2023, Published online: 20 Oct 2023

References

  • Reddel HK, Bacharier LB, Bateman ED, et al. Global Initiative for Asthma (GINA) Strategy 2021 - executive summary and rationale for key changes. Eur Respir J. 2021;205. doi:10.1183/13993003.02730-2021
  • Godard P, Chanez P, Siraudin L, Nicoloyannis N, Duru G. Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Respir J. 2002;19:61–67. doi:10.1183/09031936.02.00232001
  • Wang E, Wechsler ME, Tran TN, et al. Characterization of severe asthma worldwide: data from the International Severe Asthma Registry. Chest. 2020;157:790–804. doi:10.1016/j.chest.2019.10.053
  • Bourdin A, Fabry-Vendrand C, Ostinelli J, et al. The burden of severe asthma in France: a case-control study using a medical claims database. J Allergy Clin Immunol Pract. 2019;7:1477–1487. doi:10.1016/j.jaip.2018.12.029
  • McDonald VM, Hiles SA, Jones KA, Clark VL, Yorke J. Health-related quality of life burden in severe asthma. Med J Aust. 2018;209:S28–S33. doi:10.5694/mja18.00207
  • Voorham J, Xu X, Price DB, et al. Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma. Allergy. 2019;74:273–283. doi:10.1111/all.13556
  • Quirce S, Melero C, Huerta A, Uría E, Cuesta M. Economic impact of severe asthma exacerbations in Spain: multicentre observational study. J Asthma. 2021;58:207–212. doi:10.1080/02770903.2019.1674330
  • Nordon C, Grimaldi-Bensouda L, Pribil C, et al. Clinical and economic burden of severe asthma: a French cohort study. Respir Med. 2018;144:42–49. doi:10.1016/j.rmed.2018.10.002
  • Settipane RA, Kreindler JL, Chung Y, Tkacz J. Evaluating direct costs and productivity losses of patients with asthma receiving GINA 4/5 therapy in the United States. Ann Allergy Asthma Immunol. 2019;123:564–572.e3. doi:10.1016/j.anai.2019.08.462
  • McDonald VM, Hiles SA, Godbout K, et al. Treatable traits can be identified in a severe asthma registry and predict future exacerbations. Respirology. 2019;24:37–47. doi:10.1111/resp.13389
  • Korn S, Milger K, Skowasch D, et al. The German severe asthma patient: baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control. Respir Med. 2022;195:106793. doi:10.1016/j.rmed.2022.106793
  • Malipiero G, Paoletti G, Blasi F, et al. Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry. Expert Rev Respir Med. 2021;15:419–424. doi:10.1080/17476348.2021.1840983
  • Heffler E, Blasi F, Latorre M, et al. The severe asthma network in Italy: findings and perspectives. J Allergy Clin Immunol. 2019;7:1462–1468. doi:10.1016/j.jaip.2018.10.016
  • Canonica GW, Blasi F, Paggiaro P, et al. Oral CorticoSteroid sparing with biologics in severe asthma: a remark of the Severe Asthma Network in Italy (SANI). World Allergy Organ J. 2020;13:100464. doi:10.1016/j.waojou.2020.100464
  • Canonica GW, Malvezzi L, Blasi F, et al. Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: evidences from the Severe Asthma Network Italy (SANI) registry. Respir Med. 2020;166:105947. doi:10.1016/j.rmed.2020.105947
  • Puggioni F, Brussino L, Canonica GW, et al. Frequency of tiotropium bromide use and clinical features of patients with severe asthma in a real-life setting: data from the Severe Asthma Network in Italy (SANI) Registry. JAA. 2020;13:599–604. doi:10.2147/JAA.S274245
  • Kim S-H, Lee H, Park S-Y, et al. The Korean Severe Asthma Registry (KoSAR): real world research in severe asthma. Korean J Intern Med. 2022;37:249–260. doi:10.3904/kjim.2021.403
  • Jackson DJ, Busby J, Pfeffer PE, et al. Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era. Thorax. 2021;76:220–227. doi:10.1136/thoraxjnl-2020-215168
  • Yang F, Busby J, Heaney LG, et al. Factors Associated with Frequent Exacerbations in the UK Severe Asthma Registry. J Allergy Clin Immunol Pract. 2021;9:2691–2701.e1. doi:10.1016/j.jaip.2020.12.062
  • Newby C, Heaney LG, Menzies-Gow A, et al. Statistical cluster analysis of the British Thoracic Society Severe refractory Asthma Registry: clinical outcomes and phenotype stability. PLoS One. 2014;9:e102987. doi:10.1371/journal.pone.0102987
  • World Health Organization. Asthma: WHO’s role and activities. Available from: https://www.who.int/respiratory/asthma/activities/en/. Accessed September 18, 2023.
  • Global Asthma Network. The global asthma report; 2018. Available from: http://www.globalasthmareport.org/Global%20Asthma%20Report%202018%20EMBARGOED.pdf. Accessed September 18, 2023.
  • FitzGerald JM, Tran TN, Alacqua M, et al. International severe asthma registry (ISAR): protocol for a global registry. BMC Med Res Methodol. 2020;20:212. doi:10.1186/s12874-020-01065-0
  • Canonica GW, Alacqua M, Altraja A, et al. International Severe Asthma Registry. Chest. 2020;157:805–814. doi:10.1016/j.chest.2019.10.051
  • Bulathsinhala L, Eleangovan N, Heaney LG, et al. Development of the International Severe Asthma Registry (ISAR): a Modified Delphi Study. J Allergy Clin Immunol Pract. 2019;7:578–588.e2. doi:10.1016/j.jaip.2018.08.016
  • Dharmage SC, Bui DS, Perret J, Lowe A, Lodge C. A step in the right direction: harmonizing measures for use in asthma patient registries. J Allergy Clin Immunol. 2019;144(3):663–664. doi:10.1016/j.jaci.2019.07.005
  • Li L, Wang Z, Cui L, et al. Anaphylactic risk related to omalizumab, benralizumab, reslizumab, mepolizumab, and dupilumab. Clin Transl Allergy. 2021;11(4):e12038. doi:10.1002/clt2.12038
  • Wechsler ME, Munitz A, Ackerman SJ, et al. Eosinophils in health and disease: a State-of-the-Art review. Mayo Clin Proce. 2021;96:2694–2707.
  • Tan LD, Schaeffer B, Alismail A. Parasitic (Helminthic) Infection While on Asthma Biologic Treatment: not Everything Is What It Seems. J Asthma Allergy. 2019;12:415–420. doi:10.2147/JAA.S223402
  • Hansen S, Hilberg O, Ulrik CS, et al. The Danish severe asthma register: an electronic platform for severe asthma management and research. Eur Clin Respir J. 2021;8:1842117. doi:10.1080/20018525.2020.1842117
  • Iwanaga T, Tohda Y. Importance of clinical epidemiology research in studies on respiratory diseases. Respir Investig. 2013;51(4):217–223. doi:10.1016/j.resinv.2013.04.003
  • Sunadome H, Matsumoto H, Petrova G, et al. IL4Rα and ADAM33 as genetic markers in asthma exacerbations and type-2 inflammatory endotype. Clin Exp Allergy. 2017;47(8):998–1006. doi:10.1111/cea.12927
  • Matsumoto H, Kanemitsu Y, Nagasaki T, et al. Staphylococcus aureus enterotoxin sensitization involvement and its association with the CysLTR1 variant in different asthma phenotypes. Ann Allergy Asthma Immunol. 2017;118:197–203.
  • Sá-Sousa A, Fonseca JA, Pereira AM, et al. The Portuguese Severe Asthma Registry: development, features, and data sharing policies. Biomed Res Int. 2018;2018:1–12. doi:10.1155/2018/1495039
  • Graff S, Brusselle G, Hanon S, et al. Anti–Interleukin-5 therapy is associated with attenuated lung function decline in severe eosinophilic asthma patients from the Belgian Severe Asthma Registry. J Allergy Clin Immunol. 2022;10(2):467–477. doi:10.1016/j.jaip.2021.09.023
  • Schleich F, Brusselle G, Louis R, et al. Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR). Respir Med. 2014;108(12):1723–1732. doi:10.1016/j.rmed.2014.10.007
  • Hanon S, Brusselle G, Deschampheleire M, et al. COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry. Eur Respir J. 2020;56(6):2002857. doi:10.1183/13993003.02857-2020
  • Ambrose CS, Chipps BE, Moore WC, et al. The CHRONICLE Study of US adults with subspecialist-treated severe asthma: objectives, design, and initial results. POR. 2020;11:77–90. doi:10.2147/POR.S251120
  • Hansen ESH, Moeller AL, Backer V, et al. Severe outcomes of COVID-19 among patients with COPD and asthma. ERJ Open Res. 2021;7:00594–02020. doi:10.1183/23120541.00594-2020
  • Lombardi C, Gani F, Berti A, et al. Asthma and COVID-19: a dangerous liaison? Asthma Res Pract. 2021;7(9). doi:10.1186/s40733-021-00075-z
  • Global Initiative for Asthma (GINA). GINA Difficult-to-treat and severe asthma in adolescent and adult patients - Diagnosis and management; 2018. Available from: https://ginasthma.org/wp-content/uploads/2018/11/GINA-SA-FINAL-wms.pdf. Accessed September 18, 2023.
  • von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344–349. doi:10.1016/j.jclinepi.2007.11.008
  • Moons KGM, Altman DG, Reitsma JB, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162:W1–W73. doi:10.7326/M14-0698
  • Pottegård A, Schmidt SAJ, Wallach-Kildemoes H, et al. Data Resource Profile: the Danish National Prescription Registry. Int J Epidemiol. 2016:dyw213. doi:10.1093/ije/dyw213
  • Schmidt M, Schmidt SA, Sandegaard JL, et al. The Danish National Patient Registry: a review of content, data quality, and research potential. CLEP. 2015;449–490. doi:10.2147/CLEP.S91125
  • Schmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi:10.1007/s10654-014-9930-3
  • Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health. 2011;39(7_suppl):42–45. doi:10.1177/1403494810393562
  • Mors O, Perto GP, Mortensen PB. The Danish Psychiatric Central Research Register. Scand J Public Health. 2011;39(7_suppl):54–57. doi:10.1177/1403494810395825
  • Helweg-Larsen K. The Danish Register of Causes of Death. Scand J Public Health. 2011;39(7_suppl):26–29. doi:10.1177/1403494811399958
  • Baadsgaard M, Quitzau J. Danish registers on personal income and transfer payments. Scand J Public Health. 2011;39(7_suppl):103–105. doi:10.1177/1403494811405098
  • Grann AF, Erichsen R, Nielsen AG, Frøslev T, Thomsen R. Existing data sources for clinical epidemiology: the clinical laboratory information system (LABKA) research database at Aarhus University, Denmark. CLEP. 2011;133. doi:10.2147/CLEP.S17901
  • Jensen VM, Rasmussen AW. Danish education registers. Scand J Public Health. 2011;39(7_suppl):91–94. doi:10.1177/1403494810394715
  • Schatz M, Sorkness CA, Li JT, et al. Asthma control test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol. 2006;117:549–556. doi:10.1016/j.jaci.2006.01.011
  • Juniper EF, O′byrne PM, Guyatt GH, Ferrie PJ, King D. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902. doi:10.1034/j.1399-3003.1999.14d29.x
  • QolTech. Measurement of health-related quality of life and asthma control. Available from: https://www.qoltech.co.uk/aqlq.html. Accessed September 18, 2023.
  • EuroQol Research Foundation. EQ-5D-5L. Available from: https://euroqol.org/eq-5d-instruments/eq-5d-5l-about/. Accessed September 18, 2023.
  • Paoletti G, Pepys J, Casini M, et al. Biologics in severe asthma: the role of real-world evidence from registries. Eur Respir Rev. 2022;31:210278. doi:10.1183/16000617.0278-2021
  • Denton E, Price DB, Tran TN, et al. Cluster analysis of inflammatory biomarker expression in the International Severe Asthma Registry. J Allergy Clin Immunol. 2021;9:2680–2688.e7. doi:10.1016/j.jaip.2021.02.059
  • Heaney LG, Perez de Llano L, Al-Ahmad M, et al. Eosinophilic and Noneosinophilic Asthma. Chest. 2021;160:814–830. doi:10.1016/j.chest.2021.04.013
  • Ali N, Lyu J, Newell A, et al. Comparative effectiveness of anti-IL5/5R versus Anti-IgE in patients eligible for both (FIRE). In: Presented at ERS 2021 Meeting; 2021; Abstract #3715.
  • Pérez De Llano L, Cepelis A, Tran T, et al. Baseline characteristics of severe asthma patients initiating biologic treatment worldwide. In: Monitoring Airway Disease. European Respiratory Society; 2021:PA1106. doi:10.1183/13993003.congress-2021.PA1106
  • ISAR. Data on file for BEAM project (Understanding response and non-response to biologics); 2022.
  • Chen W, Sadatsafavi M, Bulathsinhala L, et al. Characterisation of severe, steroid-dependent asthma patients who initiate biologics versus those who do not. In: Monitoring Airway Disease. European Respiratory Society; 2021:PA1105. doi:10.1183/13993003.congress-2021.PA1105
  • Chen WJ, Sadatsafavi M, Bulathsinhala L, et al. Characterisation of severe, steroid-dependent asthma patients who initiate biologics versus those who do not. In: Presented at ERS 2021 Meeting; 2021; Abstract #2068.
  • Porsbjerg CM, Menzies-Gow AN, Tran TN, et al. Global variability in administrative approval prescription criteria for biologic therapy in severe asthma. J Allergy Clin Immunol. 2022;10(5):1202–1126. doi:10.1016/j.jaip.2021.12.027
  • Scelo G, Porsbjerg CM, Carter V, et al. Prevalence of comorbidities in adults with severe asthma: results from the International Severe Asthma Registry (ISAR). In: A34. Topics in Health Services Research and Self-Management for Patients with Obstructive Lung Disease. American Thoracic Society; 2022. doi:10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A1306.
  • Menzies-Gow AN, McBrien C, Unni B, et al. Real world biologic use and switch patterns in severe asthma: data from the International Severe Asthma Registry and the US CHRONICLE Study. JAA. 2022;15:63–78. doi:10.2147/JAA.S328653
  • Barnes PJ. Asthma-COPD Overlap. Chest. 2016;149(1):7–8. PMID: 26757281. doi:10.1016/j.chest.2015.08.017
  • Djukanovic R, Adcock IM, Anderson G, et al. The Severe Heterogeneous Asthma Research Collaboration, Patient-centred (SHARP) ERS Clinical Research Collaboration: a new Dawn in asthma research. Eur Respir J. 2018;52(5):1801671. doi:10.1183/13993003.01671-2018
  • Lougheed MD, Taite A, ten Hove J, et al. Pan-Canadian asthma and COPD standards for electronic health records: a Canadian Thoracic Society Expert Working Group Report. Can J Respir Crit Care Sleep Med. 2018;2:244–250. doi:10.1080/24745332.2018.1517623
  • Lougheed MD, Morra A, Bullock E, et al. Pan-Canadian standards for severe asthma in electronic medical records. Can J Respir Crit Care Sleep Med. 2021;5:391–399. doi:10.1080/24745332.2021.1947758

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.